Filing Details
- Accession Number:
- 0001388658-20-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-16 16:43:09
- Reporting Period:
- 2020-01-14
- Accepted Time:
- 2020-01-16 16:43:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1388658 | Irhythm Technologies Inc. | IRTC | Surgical & Medical Instruments & Apparatus (3841) | 208149544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1668499 | C. Matthew Garrett | C/O Irhythm Technologies, Inc. 699 8Th St # 600 San Francisco CA 94103 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-01-14 | 1,063 | $7.47 | 21,930 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-01-14 | 3,891 | $8.18 | 25,821 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-01-14 | 1,063 | $80.00 | 24,758 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-01-14 | 3,891 | $80.00 | 20,867 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-01-14 | 1,063 | $0.00 | 1,063 | $7.47 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-01-14 | 3,891 | $0.00 | 3,891 | $8.18 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-07-21 | No | 4 | M | Direct | |
13,108 | 2025-12-15 | No | 4 | M | Direct |
Footnotes
- The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2019
- All of the shares subject to this option are fully vested and exerciseable as of the date hereof.
- All of the shares subject to this option are fully vested and exercisable as of the date hereof.